Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 12/20 | 0.49 |
| ▸ | TACR2 | P21452 | 5/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MLNR | O43193 | 2/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6698689 | 0.83 | TACR1 (0.55) | TACR1TACR2CYP3A4CYP2D6TSHR | |
| SCHEMBL6451558 | 0.76 | TACR1 (0.47) | TACR1TACR2CYP3A4TSHR | |
| SCHEMBL31749357 | 0.73 | GPR52 (0.39) | TACR1CYP3A4CYP2D6 | |
| SCHEMBL31749308 | 0.73 | GPR52 (0.39) | TACR1CYP3A4CYP2D6 | |
| SCHEMBL31749254 | 0.73 | GPR52 (0.39) | TACR1CYP3A4CYP2D6 | |
| SCHEMBL3276041 | 0.69 | SIGMAR1 (0.53) | TACR1CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL3274127 | 0.69 | SIGMAR1 (0.53) | TACR1CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL3274123 | 0.69 | SIGMAR1 (0.53) | TACR1CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL20490877 | 0.69 | MLNR (0.47) | TACR1CYP3A4CYP2D6TSHRMEN1 | |
| SCHEMBL20490878 | 0.69 | MLNR (0.47) | TACR1CYP3A4CYP2D6TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0927170-B1 | PIPERAZINO DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORP (US) | 2003-10-08 | — | — | EP | disclosed |
| EP-0823906-B1 | PIPERAZINO DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORP (US) | 2003-07-09 | — | — | EP | disclosed |
| US-5981520-A | USEFUL FOR TREATING ASTHMA, BRONCHOSPASM, ALLERGIES, ANXIETY, COUGHING OR PAIN | SCHERING CORPORATION (US) | 1999-11-09 | — | — | US | disclosed |
| EP-0927170-A1 | PIPERAZINO DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORPORATION (US) | 1999-07-07 | — | — | EP | disclosed |
| US-5798359-A | USEFUL FOR TREATMENT OF RESPIRATORY DISORDERS SUCH AS ASTHMA | SCHERING CORPORATION (US) | 1998-08-25 | — | — | US | disclosed |
| WO-1998008826-A1 | PIPERAZINO DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORPORATION (US) | 1998-03-05 | — | — | WO | disclosed |
| EP-0823906-A1 | PIPERAZINO DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORPORATION (US) | 1998-02-18 | — | — | EP | disclosed |
| US-5719156-A | ASTHMA | SCHERING CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1996034864-A1 | PIPERAZINO DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORPORATION (US) | 1996-11-07 | — | — | WO | disclosed |